Kazakhstan Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Kazakhstan Pharmaceuticals and Healthcare Report Q3 2013 Jun 19th 2013, 00:00 BMI View: Kazakhstan remains the most attractive pharmaceutical market in Central Asia, in terms of the overall regulatory environment and ease of doing business compared to neighbouring countries. The domestic market is constrained by the relatively small size of the population and daunting infrastructure challenges. Pending World Trade Organisation (WTO) accession, expected as soon as this year, as well as Kazakhstan’s membership in the Customs Union (CU) with Russia and Belarus should drive continued improvements in regulation and harmonisation, assuming the contradictions of membership in the two groups (such as common external tariffs) can be ironed out. Meanwhile, foreign investors … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103189. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/kazakhstan-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions